HIV News and Research

RSS

Study: High percentage of chlamydia and gonorrhea patients not receiving CDC recommended treatment

Chlamydia and gonorrhea are the two most common sexually transmitted infections (STIs) in the United States, impacting 2.4 million in 2021, and the number is rising.

25 Apr 2024

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Funding represents the first time the foundation has taken an equity position in a breath diagnostics company.

From Owlstone Medical Ltd 25 Apr 2024

Researchers receive NIH grant to help develop gene therapy for HIV

Researchers at Washington University School of Medicine in St. Louis have received a $6.2 million grant from the National Institutes of Health (NIH) to develop a gene therapy that would modify the immune system's B cells to spur them to produce broadly neutralizing antibodies against HIV.

18 Apr 2024

The path to a better tuberculosis vaccine runs through Montana

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.

18 Apr 2024

Global disease burden study highlights COVID-19 impact and health inequities

Rates of early death and poor health caused by HIV/AIDS and diarrhea have been cut in half since 2010, and the rate of disease burden caused by injuries has dropped by a quarter in the same time period, after accounting for differences in age and population size across countries, based on a new study published in The Lancet. The study measures the burden of disease in years lost to early death and poor health.

17 Apr 2024

Study reveals increased risk of immune abnormalities in children of women with HIV

Researchers have found that children of women with HIV infection have an increased risk of immune abnormalities following exposure to maternal HIV viremia, immune dysfunction, and co-infections during pregnancy.

17 Apr 2024

Global HIV epidemic cannot be ended without keeping former prisoners, other patients engaged in care

New data from an implementation programme to be presented at this year's the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) stress that the global HIV epidemic cannot be ended without keeping former prisoners and other patients engaged in care, and outlines the efforts made by HIV care clinics in Chicago to locate formerly incarcerated individuals living with HIV who dropped out of care and to reconnect them with treatment services.

16 Apr 2024

Common HIV drugs linked to reduced Alzheimer's disease risk

Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need.

16 Apr 2024

Canada unlikely to eliminate Hepatitis C by 2030, study finds

Canada will not reach the original World Health Organization's (WHO) target of eliminating the Hepatitis C virus (HCV) by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University of Waterloo has found.

15 Apr 2024

Swap funds or add services? Use of opioid settlement cash sparks strong disagreements

State and local governments are receiving billions of dollars in opioid settlements to address the drug crisis that has ravaged America for decades.

15 Apr 2024

Breast milk's secret weapon against RSV revealed in new study

Researchers explored how human milk oligosaccharides (HMOs) protect infants from respiratory syncytial virus (RSV), suggesting that these components in breast milk may prevent or reduce the severity of RSV infections through multiple mechanisms including gut microbiome modulation and direct antiviral actions.

15 Apr 2024

Unveiling the key role of RNA modification in HIV-1 survival and replication

A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus's ability to survive and thrive after infecting host cells, a new study has found.

12 Apr 2024

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine hesitancy among the general public, as well as providing helpful advice on sexually transmitted infections (STIs) in conjunction with sexual health clinics, by improving knowledge and access to care.

10 Apr 2024

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

10 Apr 2024

New lab assay could make diagnosis and treatment of lung cancer easier

A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier.

10 Apr 2024

Unraveling the complex web of rectal infections and the microbiome in MSM

Study delves into the relationships between various sexually transmitted infections, including Neisseria gonorrhoeae, Chlamydia trachomatis, Torquetenovirus, and high-risk HPV, and their effects on the anorectal microbiome among men who have sex with men (MSM), unveiling complex interactions that may influence infection outcomes and treatment strategies.

10 Apr 2024

Oxford University and Brazil partner to advance malaria vaccine development

Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group - a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health - met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.

10 Apr 2024

HIV News and Research

Study: High percentage of chlamydia and gonorrhea patients not receiving CDC recommended treatment

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Researchers receive NIH grant to help develop gene therapy for HIV

The path to a better tuberculosis vaccine runs through Montana

Global disease burden study highlights COVID-19 impact and health inequities

Study reveals increased risk of immune abnormalities in children of women with HIV

Global HIV epidemic cannot be ended without keeping former prisoners, other patients engaged in care

Common HIV drugs linked to reduced Alzheimer's disease risk

Canada unlikely to eliminate Hepatitis C by 2030, study finds

Swap funds or add services? Use of opioid settlement cash sparks strong disagreements

Breast milk's secret weapon against RSV revealed in new study

Unveiling the key role of RNA modification in HIV-1 survival and replication

ChatGPT could be an effective tool to help reduce vaccine hesitancy

Rethinking the germ theory: A balanced take on microbes and disease outcomes

New lab assay could make diagnosis and treatment of lung cancer easier

Unraveling the complex web of rectal infections and the microbiome in MSM

Oxford University and Brazil partner to advance malaria vaccine development

Sugar abnormalities in the blood may promote biological aging and inflammation in HIV patients

Pioneering study launched to examine how the immune system responds to repeated malaria infections

Rogue immune cell found to cause poor antibody responses in chronic viral infections

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News